Hydra Biosciences, Inc.
ClosedCambridge, United States · Founded 2001 · $72.2M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2001
- Business Model
- B2B
- Website
- hydrabiosciences.com
- Total Funding
- $72.2M
- Last Round
- $22.0M Series EMar 2015
- Rounds
- 5
About
Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in Transient Receptor Protocols in ion channels and molecular regeneration
Summary
Hydra Biosciences, Inc. is a Biotech company based in Cambridge, United States, founded in 2001. It has raised $72.2M in total across 5 rounds, most recently a $22.0M Series E round in Mar 2015. Investors include MedImmune Ventures, Polaris Partners and Advanced Technology Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2015
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.